Thangam Cancer Center, Namakkal, is organizing a three days conference on peritoneal surface malignancies (PSM) on the 10th, ...

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...

AI based models achieved an accuracy rate of 86% for detecting ovarian cancer, compared to 82% for human experts.

Nuvectis Pharma’s NXP800 shows potential in ovarian cancer but is early stage. Find out why NVCT stock is best suited for ...

Artificial intelligence (AI)-based models developed by a team of international researchers were able to identify ovarian ...

Faye Louise, a former model, recovered from cancer after having eight organs removed due to a rare tumor called pseudomyxoma ...

In a new study led by researchers at Karolinska Institutet in Sweden, AI models did a better job of detecting ovarian cancer ...

The US Food and Drug Administration (FDA) has accepted for priority review the new drug application (NDA) for avutometinib to be used in combination with defactinib for the treatment of adults with ...

A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

BAT-8006 is under clinical development by Bio-Thera Solutions and currently in Phase II for Epithelial Ovarian Cancer.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...